Conceivex, Inc.

Conceivex, Inc. specializes in devices that support natural conception. Their primary product category is natural conception assistance kits, which include tools like semen collection devices. These are designed to help individuals or couples track and facilitate fertility at home. Examples include disposable and latex-free collection kits, such as the Conception Kit and Conceivex Latex-Free Semen Collector.

Conceivex, Inc. is headquartered in the United States. While the company’s location influences its regulatory framework—such as compliance with FDA requirements—it does not inherently determine whether its devices are authorized. Instead, individual devices undergo specific regulatory pathways like 510(k) premarket notifications or UDI listing to demonstrate safety and effectiveness before being authorized for use.

Conceivex, Inc.’s devices fall under Class II classification by the FDA. This classification is based on the agency’s risk assessment, where Class II devices require special controls beyond general controls to ensure their safety and performance. Since these devices assist with natural conception, they are subject to additional scrutiny to mitigate potential risks, such as improper use or hygiene concerns, which is why premarket notifications (like 510(k)s) and UDI listings are required.

Conceivex, Inc.’s devices are listed in the FDA’s 510(k) premarket notification database and the FDA’s Unique Device Identifier (UDI) system. The 510(k) pathway demonstrates that the company’s devices meet FDA requirements for safety and performance by showing substantial equivalence to a legally marketed predicate device. The UDI system ensures traceability and transparency in the supply chain, helping regulators and healthcare providers track devices throughout their lifecycle.

Conceivex, Inc.’s devices are classified as Class II, which mandates premarket submissions like 510(k) notifications. This process ensures that the company’s products meet FDA standards for safety and effectiveness by comparing them to a previously authorized